Free Trial

Evolent Health (EVH) Stock Price, News & Analysis

Evolent Health logo
$10.67 -0.04 (-0.37%)
As of 01:03 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Evolent Health Stock (NYSE:EVH)

Key Stats

Today's Range
$10.38
$11.03
50-Day Range
$9.60
$12.61
52-Week Range
$9.45
$35.00
Volume
2.27 million shs
Average Volume
2.15 million shs
Market Capitalization
$1.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.79
Consensus Rating
Buy

Company Overview

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Evolent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

EVH MarketRank™: 

Evolent Health scored higher than 54% of companies evaluated by MarketBeat, and ranked 382nd out of 656 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Evolent Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Evolent Health has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Evolent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Evolent Health are expected to decrease by -63.64% in the coming year, from $0.22 to $0.08 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Evolent Health is -11.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Evolent Health is -11.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Evolent Health has a P/B Ratio of 1.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Evolent Health's valuation and earnings.
  • Percentage of Shares Shorted

    9.57% of the outstanding shares of Evolent Health have been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Evolent Health has recently decreased by 1.15%, indicating that investor sentiment is improving.
  • Dividend Yield

    Evolent Health does not currently pay a dividend.

  • Dividend Growth

    Evolent Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.57% of the outstanding shares of Evolent Health have been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Evolent Health has recently decreased by 1.15%, indicating that investor sentiment is improving.
  • News Sentiment

    Evolent Health has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Evolent Health this week, compared to 5 articles on an average week.
  • Search Interest

    4 people have searched for EVH on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

EVH Stock News Headlines

KeyBanc Sticks to Their Buy Rating for Evolent Health (EVH)
Evolent Health misses Q4 estimates, shares drop on weak guidance
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?
Evolent Health reports Q4 EPS (2c), consensus 1c
Evolent Health sees Q1 revenue $440M-$447M, consensus $592.1M
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets
Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript
Evolent Announces Fourth Quarter and Full Year 2024 Results
See More Headlines

EVH Stock Analysis - Frequently Asked Questions

Evolent Health's stock was trading at $11.25 at the beginning of the year. Since then, EVH stock has decreased by 4.6% and is now trading at $10.7270.
View the best growth stocks for 2025 here
.

Evolent Health, Inc. (NYSE:EVH) posted its quarterly earnings data on Thursday, February, 20th. The technology company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.38 by $0.35. The technology company had revenue of $646.54 million for the quarter, compared to analyst estimates of $650.92 million. Evolent Health had a positive trailing twelve-month return on equity of 6.30% and a negative net margin of 2.93%.

Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Top institutional investors of Evolent Health include Vanguard Group Inc. (9.58%), Wellington Management Group LLP (8.95%), Engaged Capital LLC (4.64%) and Cadian Capital Management LP (4.48%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Emily Ann Rafferty, Diane Holder, Cheryl Scott, Mary Bridget Duffy and Steve Tutewohl.
View institutional ownership trends
.

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
2/20/2025
Today
2/21/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
Business Services
Employees
4,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.92
High Stock Price Target
$35.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+67.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

Net Income
$-113,040,000.00
Pretax Margin
-3.54%

Debt

Sales & Book Value

Annual Sales
$1.96 billion
Cash Flow
$1.82 per share
Book Value
$9.38 per share

Miscellaneous

Free Float
114,699,000
Market Cap
$1.25 billion
Optionable
Optionable
Beta
1.45

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:EVH) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners